Scaling busulfan dose to body size in children
Treatments studied
This study tests a different way to calculate how much busulfan (a medicine used before a stem cell transplant) to give to children. By using body surface area (a measure of body size), they hope to find the right dose for each child.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years old or younger
- You are scheduled to receive busulfan once a day as part of your treatment before a bone marrow transplant
- You have a body surface area measurement taken to determine your dose group
- You have not taken certain medicines (like some antifungals or seizure medicines) within a required waiting period before starting the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well a donor bone marrow (stem cell) transplant works for people with inherited immune system problems (called immune deficiencies). It’s for patients who haven’t improved with usual treatment or don’t have another good option.
This trial tests whether giving a lower dose of cyclophosphamide after a bone marrow transplant can be safer for older or medically “unfit” patients, while still helping control blood cancers. It is designed for people who can’t tolerate the usual strongest transplant preparation.
This Phase 2 study tests an immune-suppressing treatment for people with sickle cell disease or beta-thalassemia who are preparing for a stem cell transplant from a donor. It aims to help the transplant work better by changing the immune response.
This trial tests a personalized way to adjust busulfan dosing (a chemotherapy drug) during an allogeneic stem cell transplant conditioning regimen. It aims to help adults who cannot receive the usual “high-intensity” conditioning due to age or other health problems.
This study looks at how to collect and handle blood samples from people receiving IV busulfan, a chemotherapy medicine. It may help improve the process of monitoring treatment by ensuring samples are collected correctly.
This study watches how the chemotherapy drug Treosulfan works in children getting a stem cell transplant. The goal is to make sure the dose is just right for each child.
Hear when a new Glutathione trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.